Source and scope
This summary is bounded to the recommendations, population and decisions covered by ACG and CAG Clinical Guideline: Management of Dyspepsia. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CAG dyspepsia
Source-attributed clinical priorities
- Assess dysphagia, bleeding, anemia, weight loss, vomiting, family history, medicine exposure and gastric-cancer risk before empiric care.
- Use the CAG age- and risk-informed pathway for endoscopy, Helicobacter pylori testing and acid suppression.
- Review response and step down unnecessary long-term acid suppression while escalating progressive dysphagia or bleeding urgently.
- Progressive dysphagia is an alarm feature and should not be managed as uncomplicated reflux.
sources for this section:CAG dyspepsia
Practical assessment and management workflow
1
Characterize epigastric pain, heartburn, regurgitation, swallowing, bleeding, weight and medication exposure.
2
Assess age and cancer risk and test for Helicobacter pylori or arrange endoscopy through the CAG pathway.
3
Use a time-limited acid-suppression or eradication plan tied to the working diagnosis.
4
Confirm eradication when indicated and step down long-term proton-pump inhibition when no continuing indication remains.
sources for this section:CAG dyspepsia
Safety, red flags and urgent escalation
- Hematemesis, melena, hemodynamic compromise or food-bolus obstruction needs urgent care.
- Anemia, persistent vomiting, progressive dysphagia or unexplained weight loss requires expedited investigation.
- Review magnesium, B12, fracture, kidney and infection context when long-term acid suppression continues.
sources for this section:CAG dyspepsia
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CAG dyspepsia
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CAG dyspepsia
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Association of GastroenterologyACG and CAG Clinical Guideline: Management of Dyspepsiaaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.